Adrian Kruit1, Pieter Zanen2. 1. Medical laboratory, Nij Smellinghe Hospital, Compagnonsplein 1, 9209 NN Drachten, the Netherlands. Electronic address: a.kruit@nijsmellinghe.nl. 2. Department of Pulmonology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. Electronic address: p.zanen@umcutrecht.nl.
Abstract
OBJECTIVE: A direct, inverse correlation between 25-hydroxy vitamin D (25(OH) vitamin D) levels and C-reactive protein (CRP), a sensitive biomarker for inflammation, was found in some, but not all, studies. These effects were seen in healthy subjects as well as in some inflammatory diseases. DESIGN AND METHODS: CRP and 25(OH) vitamin D data (2011-2013) from 923 in- and outpatients (males/females 340/583; median age: 76years (95% confidence interval (CI): 75-77) were analyzed. A standardized diagnosis according to the Dutch diagnosis coding standard for each patient was obtained. Each diagnosis was categorized as either inflammatory or non-inflammatory disease. Analysis of variance was performed with age, gender, inflammatory status (inflammatory disease/non-inflammatory disease), and season as corrective factors. RESULTS: The correlation between (log) ln-25(OH) vitamin D and ln-CRP was highly significant (p<0.001) with a regression coefficient of -0.879. In the inflammatory disease group, the R(2) value was 0.726 and in the non-inflammatory disease group it was 0.502. It was shown that increasing 25(OH) vitamin D levels are associated with decreasing CRP levels, with a stronger effect in the inflammatory disease group compared to the non-inflammatory disease group. CONCLUSIONS: Our study shows an inverse correlation between 25(OH) vitamin D and CRP in a large patient cohort but more importantly shows that this effect is more pronounced in patients with inflammatory diseases compared to patients with non-inflammatory diseases.
OBJECTIVE: A direct, inverse correlation between 25-hydroxy vitamin D (25(OH) vitamin D) levels and C-reactive protein (CRP), a sensitive biomarker for inflammation, was found in some, but not all, studies. These effects were seen in healthy subjects as well as in some inflammatory diseases. DESIGN AND METHODS: CRP and 25(OH) vitamin D data (2011-2013) from 923 in- and outpatients (males/females 340/583; median age: 76years (95% confidence interval (CI): 75-77) were analyzed. A standardized diagnosis according to the Dutch diagnosis coding standard for each patient was obtained. Each diagnosis was categorized as either inflammatory or non-inflammatory disease. Analysis of variance was performed with age, gender, inflammatory status (inflammatory disease/non-inflammatory disease), and season as corrective factors. RESULTS: The correlation between (log) ln-25(OH) vitamin D and ln-CRP was highly significant (p<0.001) with a regression coefficient of -0.879. In the inflammatory disease group, the R(2) value was 0.726 and in the non-inflammatory disease group it was 0.502. It was shown that increasing 25(OH) vitamin D levels are associated with decreasing CRP levels, with a stronger effect in the inflammatory disease group compared to the non-inflammatory disease group. CONCLUSIONS: Our study shows an inverse correlation between 25(OH) vitamin D and CRP in a large patient cohort but more importantly shows that this effect is more pronounced in patients with inflammatory diseases compared to patients with non-inflammatory diseases.
Authors: Ruibin Wang; Michael G Shlipak; Joachim H Ix; Todd T Brown; Lisa P Jacobson; Frank J Palella; Jordan E Lake; Susan L Koletar; Richard D Semba; Michelle M Estrella Journal: J Acquir Immune Defic Syndr Date: 2019-01-01 Impact factor: 3.731
Authors: Edwin Hoe; Jordan Nathanielsz; Zheng Quan Toh; Leena Spry; Rachel Marimla; Anne Balloch; Kim Mulholland; Paul V Licciardi Journal: Nutrients Date: 2016-12-12 Impact factor: 5.717
Authors: Katarzyna Krasowska; Wojciech Skrobot; Ewelina Liedtke; Piotr Sawicki; Damian Jozef Flis; Katarzyna Patrycja Dzik; Witold Libionka; Wojciech Kloc; Jan Jacek Kaczor Journal: Front Pharmacol Date: 2019-05-22 Impact factor: 5.810
Authors: Thomas Ebert; Sven-Christian Pawelzik; Anna Witasp; Samsul Arefin; Sam Hobson; Karolina Kublickiene; Paul G Shiels; Magnus Bäck; Peter Stenvinkel Journal: Toxins (Basel) Date: 2020-04-04 Impact factor: 4.546